{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:52:42Z","timestamp":1784335962470,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/bcmd.2001.0452","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T10:51:07Z","timestamp":1032173467000},"page":"825-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["PBK\/TOPK Is a Novel Mitotic Kinase Which Is Upregulated in Burkitt's Lymphoma and Other Highly Proliferative Malignant Cells"],"prefix":"10.1006","volume":"27","author":[{"given":"Michelle","family":"Simons-Evelyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Bailey-Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Toretsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas D.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhan","family":"Kalvakolanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/bcmd.2001.0452_RF1","first-page":"518a","article-title":"Identification of differentially expressed genes in a human Burkitt's lymphoma cell line using differential mRNA display","volume":"94","author":"Rapoport","year":"1999","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0452_RF2","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1073\/pnas.090102397","article-title":"Characterization of PDZ-binding kinase, a mitotic kinase","volume":"97","author":"Gaudet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bcmd.2001.0452_RF3","doi-asserted-by":"crossref","first-page":"21525","DOI":"10.1074\/jbc.M909629199","article-title":"Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells","volume":"275","author":"Abe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bcmd.2001.0452_RF4","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood.V97.8.2522","article-title":"A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death","volume":"97","author":"Steensma","year":"2001","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0452_RF5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V72.1.219.219","article-title":"Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma","volume":"72","author":"Greipp","year":"1988","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0452_RF6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/028418699432040","article-title":"Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers","volume":"38","author":"Holte","year":"1999","journal-title":"Acta Oncol."},{"key":"10.1006\/bcmd.2001.0452_RF7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01417.x","article-title":"Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: Independent prognostic value of p27Kip1","volume":"105","author":"Moller","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1006\/bcmd.2001.0452_RF8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bcmd.2001.0428","article-title":"Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes","volume":"27","author":"Rapoport","year":"2001","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1006\/bcmd.2001.0452_RF9","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1200\/JCO.1998.16.9.2986","article-title":"Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms","volume":"16","author":"Senderowicz","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/bcmd.2001.0452_RF10","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1517\/13543784.9.12.2903","article-title":"Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: Current status","volume":"12","author":"Kelland","year":"2000","journal-title":"Expert Opin. Invest. Drugs"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979601904528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979601904528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:16:20Z","timestamp":1761048980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979601904528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S1079979601904528"],"URL":"https:\/\/doi.org\/10.1006\/bcmd.2001.0452","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PBK\/TOPK Is a Novel Mitotic Kinase Which Is Upregulated in Burkitt's Lymphoma and Other Highly Proliferative Malignant Cells","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/bcmd.2001.0452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Science (USA). All rights reserved.","name":"copyright","label":"Copyright"}]}}